Kushco Holdings Inc Receivables Turnover Ratio (KSHB), from the third quarter 2021 to the third quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Kushco Holdings Inc   (KSHB)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Kushco Holdings Inc Accounts Receivables Turnover Ratio from the third quarter 2021 to the third quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Kushco Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2021 to a ratio of 11.69, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the third quarter 2021. Average receivable collection period, for the Kushco Holdings Inc in May 31 2021 quarter, has decreased to 31 days, compared to 36 days, in the Feb 28 2021 quarter.

If we take a look into Healthcare sector 110 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1320.

What is Receivable Turnover Ratio?
What is Kushco Holdings Inc Selling?


What is Receivable Turnover Ratio?





KSHB Receivables Turnover Ratio (May 31 2021)
III. Quarter
(Feb 28 2021)
II. Quarter
(Nov 30 2020)
I. Quarter
(Aug 31 2020)
IV. Quarter
(May 31 2020)
III. Quarter
Y / Y Receivable Change -33.72 % -38.02 % -55.36 % -63.7 % -23.04 %
Y / Y Revenue Change 27.2 % 9.09 % -23.46 % -44.54 % -46.33 %
Receivable Turnover Ratio (TTM) 11.69 10.1 8.57 7.1 6.71
KSHB's Total Ranking # 1320 # 1320 # 1320 # 1021 # 1903
Accounts Receivable average collection period days 31 36 43 51 54
Seq. Receivable Change -29.2 % -12.63 % 26.86 % -15.54 % -33.8 %
Seq. Revenue Change -13.88 % 22.88 % 0.32 % 19.82 % -26.14 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 111
Overall Market # 1320

Receivable Turnover Ratio Statistics
High Average Low
1.03 0.74 0.37
(Aug 31 2019)   (May 31 2017)






Financial Statements
Kushco Holdings Inc 's Accounts Receivable $ 7 Millions Visit KSHB's Balance sheet
Kushco Holdings Inc 's Sales TTM $ 115 Millions Visit KSHB's Income Statement
Sources of KSHB's Revenues Visit KSHB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KSHB's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KSHB's Growth Rates KSHB's Roa KSHB's Inventory Turnover Ratio KSHB's Dividend Comparisons
KSHB's Profitability Ratios KSHB's Roi KSHB's Asset Turnover Ratio KSHB's Dividend Growth
KSHB's Valuation Ratios KSHB's Roe KSHB's Financial Strength Ratios KSHB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending May 31 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending May 31 2021 Receivable at quarter ending May 31 2021
Electromedical Technologies Inc   41.64 $ 0.756  Millions$ 0.018  Millions
Editas Medicine Inc   40.04 $ 81.138  Millions$ 2.027  Millions
Brookdale Senior Living Inc   38.76 $ 3,183.717  Millions$ 82.134  Millions
National Vision Holdings Inc   37.15 $ 2,065.718  Millions$ 55.609  Millions
Immunogen inc   36.85 $ 136.641  Millions$ 3.708  Millions
Nurix Therapeutics Inc   36.07 $ 22.876  Millions$ 0.634  Millions
Novavax inc   31.46 $ 937.808  Millions$ 29.811  Millions
Affimed N v   31.30 $ 11.693  Millions$ 0.374  Millions
Advanced Container Technologies Inc   30.59 $ 4.010  Millions$ 0.131  Millions
Blueprint Medicines Corporation  29.81 $ 831.576  Millions$ 27.900  Millions
Cardiff Lexington Corporation  27.31 $ 4.457  Millions$ 0.163  Millions
Cyclerion Therapeutics Inc   27.29 $ 3.595  Millions$ 0.132  Millions
Intellia Therapeutics Inc   26.58 $ 41.810  Millions$ 1.573  Millions
Molecular Templates Inc   25.99 $ 26.149  Millions$ 1.006  Millions
G1 Therapeutics Inc   24.97 $ 63.967  Millions$ 2.562  Millions
Endonovo Therapeutics Inc   24.87 $ 0.116  Millions$ 0.005  Millions
Delcath Systems Inc   24.48 $ 1.897  Millions$ 0.078  Millions
Ensysce Biosciences Inc   23.60 $ 0.445  Millions$ 0.019  Millions
Ideaya Biosciences Inc   23.21 $ 35.541  Millions$ 1.531  Millions
Butterfly Network Inc   23.15 $ 83.270  Millions$ 3.597  Millions
Ethema Health Corporation   22.42 $ 0.360  Millions$ 0.016  Millions
Grapefruit Usa Inc   22.06 $ 2.831  Millions$ 0.128  Millions
China Pharma Holdings Inc  22.04 $ 10.106  Millions$ 0.458  Millions
Agape Atp Corporation  21.72 $ 2.534  Millions$ 0.117  Millions
Catalyst Pharmaceuticals Inc   21.37 $ 126.902  Millions$ 5.938  Millions
Harrow Inc   21.17 $ 62.571  Millions$ 2.955  Millions
Reflect Scientific Inc  20.15 $ 3.559  Millions$ 0.177  Millions
Innovage Holding Corp   19.53 $ 637.801  Millions$ 32.661  Millions
Talkspace Inc   19.00 $ 31.433  Millions$ 1.654  Millions
Revance Therapeutics Inc   18.39 $ 47.071  Millions$ 2.560  Millions

Date modified: 2026-08-29T17:31:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.